These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20104074)

  • 1. Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study.
    Colenda CC; Legault C; Rapp SR; DeBon MW; Hogan P; Wallace R; Hershey L; Ockene J; Whitmer R; Phillips LS; Sarto GE
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):177-86. PubMed ID: 20104074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study.
    Goveas JS; Espeland MA; Woods NF; Wassertheil-Smoller S; Kotchen JM
    J Am Geriatr Soc; 2011 Jan; 59(1):57-66. PubMed ID: 21226676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between depressive symptoms and subtypes of mild cognitive impairment in post-menopausal women: Results from the Women's Health Initiative Memory Study.
    Korthauer LE; Goveas JS; Rapp SR; Espeland MA; Shumaker SA; Garcia KR; Rossom RC; Garcia L; Tindle HA; Salmoirago-Blotcher E; Wassertheil-Smoller S; Zaslavsky O; Cochrane B; Sink KM; Masaki K; Driscoll I
    Int J Geriatr Psychiatry; 2022 Nov; 37(11):. PubMed ID: 36205005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study.
    Johnson KC; Margolis KL; Espeland MA; Colenda CC; Fillit H; Manson JE; Masaki KH; Mouton CP; Prineas R; Robinson JG; Wassertheil-Smoller S;
    J Am Geriatr Soc; 2008 Aug; 56(8):1449-58. PubMed ID: 18637980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory Study.
    Kerwin DR; Gaussoin SA; Chlebowski RT; Kuller LH; Vitolins M; Coker LH; Kotchen JM; Nicklas BJ; Wassertheil-Smoller S; Hoffmann RG; Espeland MA;
    J Am Geriatr Soc; 2011 Jan; 59(1):107-12. PubMed ID: 21226681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
    Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
    Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.
    Shumaker SA; Reboussin BA; Espeland MA; Rapp SR; McBee WL; Dailey M; Bowen D; Terrell T; Jones BN
    Control Clin Trials; 1998 Dec; 19(6):604-21. PubMed ID: 9875839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone replacement therapy and cognitive function].
    Huang CP; Hong CT; Huang IT
    Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational attainment, MRI changes, and cognitive function in older postmenopausal women from the Women's Health Initiative Memory Study.
    Rapp SR; Espeland MA; Manson JE; Resnick SM; Bryan NR; Smoller S; Coker LH; Phillips LS; Stefanick ML; Sarto GE;
    Int J Psychiatry Med; 2013; 46(2):121-43. PubMed ID: 24552037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol.
    Gaussoin SA; Espeland MA; Absher J; Howard BV; Jones BM; Rapp SR
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):205-14. PubMed ID: 21416508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study.
    Rapp SR; Legault C; Henderson VW; Brunner RL; Masaki K; Jones B; Absher J; Thal L
    Alzheimer Dis Assoc Disord; 2010; 24(3):248-55. PubMed ID: 20473134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.
    Driscoll I; Shumaker SA; Snively BM; Margolis KL; Manson JE; Vitolins MZ; Rossom RC; Espeland MA
    J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1596-1602. PubMed ID: 27678290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
    Coker LH; Espeland MA; Rapp SR; Legault C; Resnick SM; Hogan P; Gaussoin S; Dailey M; Shumaker SA
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):304-10. PubMed ID: 19932751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study.
    Padula CB; Weitlauf JC; Rosen AC; Reiber G; Cochrane BB; Naughton MJ; Li W; Rissling M; Yaffe K; Hunt JR; Stefanick ML; Goldstein MK; Espeland MA
    Gerontologist; 2016 Feb; 56(1):115-25. PubMed ID: 26615021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.